NTLA Intellia Therapeutics
- 20.760
- +0.740+3.70%
- 20.800
- +0.040+0.19%
Intellia Therapeutics所有资讯
Intellia Therapeutics | 3：首次持股声明-高管 Dube Michael P
Intellia Therapeutics | 4：持股变动声明-高管 Sepp-Lorenzino Laura
Intellia Therapeutics | 4：持股变动声明-高管 BASTA JAMES
Intellia Therapeutics | 4：持股变动声明-高管 Hicks Derek
Intellia Therapeutics | 4：持股变动声明-高管 Clark Eliana
Intellia Therapeutics | 4：持股变动声明-高管 Goddard Glenn
Intellia Therapeutics | 4：持股变动声明-高管 Lebwohl David
Intellia Therapeutics | 4：持股变动声明-高管 LEONARD JOHN M
Intellia Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(9.32%)
Intellia Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-ARK Investment Management LLC(12.74%)
Intellia Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(5.29%)
Intellia Therapeutics | 4：持股变动声明-高管 Sepp-Lorenzino Laura
Intellia Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(10.1%)
Intellia Therapeutics | 4：持股变动声明-高管 LEONARD JOHN M
Intellia Therapeutics | 4：持股变动声明-高管 Goddard Glenn
Intellia Therapeutics | 4：持股变动声明-高管 Sepp-Lorenzino Laura
Intellia Therapeutics | 4：持股变动声明-高管 Lebwohl David
Intellia Therapeutics | 4：持股变动声明-高管 Hicks Derek
Intellia Therapeutics | 4：持股变动声明-高管 Clark Eliana
Intellia Therapeutics | 4：持股变动声明-高管 BASTA JAMES
分析
目标价预测
暂无数据
